An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1

Haibin Deng,Huixiang Ge,Christelle Dubey,Tereza Losmanova,Michaela Medová,Georgia Konstantinidou,Seyran Mathilde Mutlu,Fabienne Esther Birrer,Tess Melinda Brodie,Deborah Stroka,Wenxiang Wang,Ren-Wang Peng,Patrick Dorn,Thomas Michael Marti
DOI: https://doi.org/10.1007/s00262-023-03542-z
IF: 6.63
2023-10-07
Cancer Immunology Immunotherapy
Abstract:The inducible Kras/p53 lung adenocarcinoma mouse model, which faithfully recapitulates human disease, is routinely initiated by the intratracheal instillation of a virus-based Cre recombinase delivery system. Handling virus-based delivery systems requires elevated biosafety levels, e.g., biosafety level 2 (BSL-2). However, in experimental animal research facilities, following exposure to viral vectors in a BSL-2 environment, rodents may not be reclassified to BSL-1 according to standard practice, preventing access to small animal micro-computed tomography (micro-CT) scanners that are typically housed in general access areas such as BSL-1 rooms. Therefore, our goal was to adapt the protocol so that the Cre-induced KP mouse model could be handled under BSL-1 conditions during the entire procedure.
oncology,immunology
What problem does this paper attempt to address?